Gene: GABRA5
Official Full Name: gamma-aminobutyric acid type A receptor subunit alpha5provided by HGNC
Gene Summary: GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Transcript variants utilizing three different alternative non-coding first exons have been described. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37771 | GABRA5 Knockout cell line (HEK293) | Human | GABRA5 | 1:3~1:6 | Negative | Online Inquiry |
KO37772 | GABRA5 Knockout cell line (A549) | Human | GABRA5 | 1:3~1:4 | Negative | Online Inquiry |
GABRA5 Gene Knockout Cell Lines are specialized cellular models engineered to lack the GABRA5 gene, which encodes a subunit of the GABA-A receptor, crucial in mediating inhibitory neurotransmission in the central nervous system. These cell lines are invaluable tools for researchers studying the intricacies of synaptic transmission, neuropharmacology, and the pathophysiology of neurological disorders. By disrupting this specific gene, the cell lines provide insights into the functional outcomes of reduced GABAergic signaling, thereby elucidating the role of GABRA5 in various physiological processes.
The mechanisms by which GABRA5 Gene Knockout Cell Lines function involve the direct absence of the GABRA5 protein, leading to altered receptor composition and functionality across GABA-A receptor complexes. As a result, researchers can investigate the resulting phenotypic changes, including modifications in neuronal excitability, synaptic plasticity, and behavior at both molecular and systemic levels. This tool is particularly critical in the examination of conditions such as anxiety, epilepsy, and schizophrenia, where GABAergic signaling is implicated.
In terms of scientific importance, these knockout models are essential for drug discovery and development, especially for compounds aimed at modulating GABA-A receptor activity. Their application in preclinical studies allows for a better understanding of drug efficacy and mechanism of action. Compared to traditional methods, such as pharmacological inhibition, GABRA5 Gene Knockout Cell Lines provide a more definitive and controlled approach to studying gene function and its effects on cellular and systemic physiology.
The specific advantages of using these cell lines include precise genetic manipulation, reproducibility of results, and incorporation into high-throughput screening assays, making them attractive for both academic and commercial research settings. Their ability to deliver clear insights into the gene's role and the subsequent effects on cellular behavior positions them as superior alternatives to other models.
For researchers and clinicians interested in neurobiology and related fields, GABRA5 Gene Knockout Cell Lines offer a unique opportunity to explore the complexities of inhibitory signaling pathways. Company expertise in genetic editing technologies further enhances the reliability and precision of our product offerings, ensuring that users receive high-quality, robust material to facilitate their innovative research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.